GENENTECH STANDS BY YOUR RITUXAN PATIENTS
If your patients:
If your patients:
†To be eligible for free Genentech medicine from the Genentech Patient Foundation, insured patients who have coverage for their medicine should try to pursue other forms of financial assistance, if available, and meet certain income requirements. Uninsured patients and insured patients without coverage for their medicine must meet a different set of income requirements.
‡This Rituxan Immunology Product and Administrative Co-pay Programs are valid ONLY for patients with commercial insurance who have a valid prescription for a Food and Drug Administration (FDA)-approved indication of a Genentech medication. Patients using Medicare, Medicaid or any other federal or state government program to pay for their medications are not eligible. To receive co-pay assistance for both drug cost and administration fees, patients must apply for and be enrolled in each type of program benefit, i.e., drug cost and administration fees.
Under the programs, the patient will pay a co-pay for drug costs and a co-pay for administration costs. After reaching the maximum per treatment or annual limit, the patient will be responsible for all remaining out-of-pocket expenses. The amount of the program’s benefits cannot exceed the patient’s out-of-pocket expenses for the cost of the drug or administration fees associated with Rituxan.
All participants are responsible for reporting the receipt of all program benefits as required by any insurer or by law. No party may seek or receive payment or reimbursement for all or any part of the out-of-pockets costs covered through these programs. The programs are only valid in the United States and U.S. Territories. These programs are void where prohibited by law. The product co-pay program shall follow state restrictions in relation to AB-rated generic equivalents (e.g., MA, CA) where applicable. The administration co-pay program is not valid in Massachusetts, Michigan, or Rhode Island residents.
Genentech, Inc. reserves the right to rescind, revoke or amend the program without notice at any time. The patient, guardian, prescriber, hospital and any other person using or administering the programs agree not to seek reimbursement for all or any part of the benefit received by the patient through the offer of this program. Additional Terms and Conditions apply. Please visit racopay.com/rituxan/terms-and-conditions for the full list of Terms and Conditions.
‖Genentech does not influence or control the operations or eligibility criteria of any independent co-pay assistance foundation and cannot guarantee co-pay assistance after a referral from Rituxan Immunology Access Solutions. The foundations to which we refer patients are not exhaustive or indicative of Genentech’s endorsement or financial support. There may be other foundations to support the patient's disease state.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.